PRNP and prion disease: Consistent with a role for PrPC as a neurotoxic mediator, there is evidence that prion disease progression in mice is characterized by two, mechanistically distinct phases: rapid accumulation of PrPSc and infectivity, followed by slower development of neuropathology and clinical symptoms over a time course that is inversely related to expression levels of PrPC [10, 11].